Navigation Links
Harmonizing biobank research: An achievable world-wide goal
Date:3/13/2009

National biobanks play a vital role in modern health research by providing a goldmine of stored human biological samples and data, but they are expensive to run. Can we make better use of these invaluable resources by collaborating across national borders on a larger scale? This is the theme of an international conference being held in March 2009.

How can we maximize the value and use of biobanks through harmonization?

The conference is co-organised by PHOEBE (Promoting Harmonization of Epidemiological Biobanks in Europe), P3G (Public Population Project in Genomics) and BBMRI (Biobanking and Biomolecular Resources Research Infrastructure) and will take place on the 25th 27th March 2009 in Brussels, Belgium. Bringing together leading scientists at the cutting-edge of genomic and biobank-based research the conference will discuss new directions in international harmonisation of biobanks.

Over 250 participants from over 30 countries are expected to attend the meeting. P3G and BBMRI will also hold their annual meetings prior to this conference.

The conference begins on March 25th with a keynote address by Professor Ruth Chadwick from the University of Cardiff about Harmonisation and Ethics. On the following two days there will be a range of scientific sessions where over 25 experts from around the world will address issues about how to get the best value and use from harmonised biobanks.

Venue:
Thon Hotel Brussels City Centre
Avenue du Boulevard 17
B-1210 Brussels, Belgium

If you would like to attend but have not yet registered, or would like to arrange an interview with any of the conference speakers, please contact Elisabeth Shaw (Elisabeth.shaw@fhi.no, +47-21-07-83-98).

ABOUT THE ORGANISERS

PHOEBE
PHOEBE is a coordination action funded by the 6th Framework Program of the European Commission. It is coordinated by Dr. Jennifer Harris at the Norwegian Institute of Public Health and includes 18 partners in 13 countries. PHOEBE identifies and explores key issues to help to ensure that Europe makes best use of its rich array of population-based biobanks and longitudinal cohort studies. The ultimate aim is to harmonise those features that will help to: (1) promote communication between major biobanking initiatives; (2) enhance the effective sharing and synthesis of information and data; and (3) avoid the expensive mistakes and inefficiencies that can arise when individual initiatives repeatedly "re-invent the wheel". PHOEBE work is broadly focused around five main themes: epidemiology and biostatistics, opportunities for future biobanking in Europe, database and biobank information management systems, strategies for genotyping in large scale studies, and ethical and societal issues.

P3G
The Public Population Project in Genomics (P3G) is a not-for-profit international consortium to promote collaboration between researchers in the field of population genomics.

It has been launched in order to provide the international population genomics community with the resources, tools and know-how to facilitate data management for improved methods of knowledge transfer and sharing.

Its main objective consists in the creation of an open, public and accessible knowledge database. The motto is transparency and collaboration.

BBMRI
BBMRI is a project funded by the 7th Framework Program of the European Commission. Its mission is to prepare for the construction of a pan-European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI) for biomedical and biological research, building on existing infrastructures, resources and technologies, specifically complemented with innovative components and properly embedded into European ethical, legal and societal frameworks.


'/>"/>

Contact: Elisabeth Shaw
elisabeth.shaw@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Related biology news :

1. Harmonizing Biobank Research Conference in 2009
2. Manchester clears first hurdle in €170 million biobank building boom
3. Paradigm shift in Alzheimerss research: new treatments
4. New research: Fruit juice consumption not related to overweight in children
5. Advances in the field of schizophrenia research: New genetic factors identified
6. Robotics research: Enhancing the lives of people with disabilities
7. Geisinger research: Antimalarial drug prevents diabetes in arthritis patients
8. K-State research: Freshwater pollution costs US at least $4.3 billion a year
9. Toothsome research: Deducing the diet of a prehistoric hominid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/23/2017)... , Aug. 23, 2017  The general public,s help is being enlisted ... bacteria that live in and on the human body –and are believed ... The Microbiome Immunity ... human microbiome, starting with the gut. The project's goal is to help ... credit: IBM ...
(Date:6/30/2017)... 2017 Today, American Trucking Associations announced ... face and eye tracking software, became the newest ... "Artificial intelligence and advanced sensing ... a driver,s attentiveness levels while on the road.  ... detect fatigue and prevent potential accidents, which could ...
(Date:5/23/2017)... robotic gym for the rehabilitation and functional motor sense evaluation of lower ... . The first 30 robots will be available from June in ... The technology was developed and patented at the IIT laboratories and has ... to a 10 million euro investment from entrepreneur Sergio Dompè. ... ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... At ... Purple announced Dr. Suneel I. Sheikh, the co-founder, CEO and chief research scientist ... has been selected for membership in ARCS Alumni Hall of Fame . ...
(Date:10/11/2017)... ... October 11, 2017 , ... ComplianceOnline’s Medical Device Summit is back for ... June 2018 in San Francisco, CA. The Summit brings together current and former FDA ... board directors and government officials from around the world to address key issues in ...
(Date:10/11/2017)... HILLS, Calif. , Oct. 11, 2017  SkylineDx today ... (ICR) and University of Leeds ... risk-stratify patients with multiple myeloma (MM), in a multi-centric Phase ... University of Leeds is the sponsor ... and ICR will perform the testing services to include high-risk ...
(Date:10/11/2017)... , ... October 11, 2017 , ... ... (FDA) has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer ... treatment of osteosarcoma. SBT-100 is able to cross the cell membrane and bind ...
Breaking Biology Technology: